🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Advanced Soft-tissue Sarcoma

A Study of MT-4561 in Patients With Various Advanced Solid Tumors NCT06943521Phase 1, Phase 26 sites📍 Los Angeles📍 Grand Rapids📍 Columbus Tanabe Pharma America, Inc. · Tests: MT-4561 Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, AXIOM Trial NCT05333458Phase 213 sites📍 Los Angeles📍 Los Angeles📍 Los Angeles National Cancer Institute (NCI) · Tests: Atezolizumab, Biopsy Procedure, Biospecimen Collection, Computed Tomography, Echocardiography Test Brachytherapy (Iodine-125 Seeds) and Fluzoparib Combination Therapy for Advanced Unresectable Soft Tissue Sarcoma NCT05894018Phase 21 site📍 Guangzhou Fujun Zhang · Tests: Fluzoparib, Radioactive particle implantation Study of NY-ESO-1 TCR-T in Advanced Soft Tissue Sarcoma NCT05620693NA1 site📍 Shenzhen Shenzhen University General Hospital · Tests: NY-ESO-1 TCR-T AB122 Platform Study NCT04999761Phase 19 sites📍 Aichi📍 Chiba📍 Ehime Taiho Pharmaceutical Co., Ltd. · Tests: AB122, AB122, TAS-116, TAS-120, TAS-115 I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer NCT01042379Phase 242 sites📍 Birmingham📍 Scottsdale📍 Tucson QuantumLeap Healthcare Collaborative · Tests: Standard Therapy, AMG 386 with or without Trastuzumab, AMG 479 (Ganitumab) plus Metformin, MK-2206 with or without Tras… Talimogene Laherparepvec, Nivolumab and Trabectedin for Sarcoma NCT03886311Phase 21 site📍 Santa Monica Sarcoma Oncology Research Center, LLC · Tests: Talimogene Laherparepvec 100000000 PFU/1 ML Injection Suspension [IMLYGIC], Nivolumab IV Soln 100 MG/10ML, Trabectedin … A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors NCT06440005Phase 17 sites📍 Los Angeles📍 Sarasota📍 St Louis Angiex, Inc. · Tests: AGX101 Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration NCT04040205Phase 24 sites📍 Jacksonville📍 Iowa City📍 St Louis Medical College of Wisconsin · Tests: Abemaciclib XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma NCT06571734Phase 21 site📍 Chicago Northwestern University · Tests: Biospecimen Collection, Computed Tomography, Echocardiography, Multigated Acquisition Scan, Zanzalintinib An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With Advanced Solid Tumors NCT06942143Phase 11 site📍 Guangzhou Guangzhou FineImmune Biotechnology Co., LTD. · Tests: Super1 TCR-T Cryoablation Plus Camrelizumab for Advanced Soft Tissue Sarcoma NCT07602049Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Cryoablation therapy + anti-PD-1 antibody Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas NCT07066982Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: CD146/HER2 CAR-T cells EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors NCT07410676Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: EBNK-001 + IL-15 + Pembrolizumab Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors NCT06132503Phase 11 site📍 West Valley City Lantern Pharma Inc. · Tests: LP-284 Multicohort Trial of Different Schemes of PM14 in Monotherapy and in Combination with Radiotherapy in Soft Tissue Sarcomas and Other Solid Tumor NCT05146440Phase 1, Phase 24 sites📍 Zaragoza📍 Barcelona📍 Barcelona Grupo Espanol de Investigacion en Sarcomas · Tests: PM14 Actinium Therapy for Late-stage Aggressive Sarcomas NCT07156565Phase 16 sites📍 Los Angeles📍 Rochester📍 New York Ratio Therapeutics, Inc. · Tests: [Ac 225]RTX-2358, [Cu64]LNTH-1363S Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS) NCT03016819Phase 324 sites📍 Phoenix📍 Los Angeles📍 Santa Monica Advenchen Laboratories, LLC · Tests: AL3818, Dacarbazine, AL3818 or placebo, Midazolam 2 mg for CYP3A4 phenotyping, Digoxin (0.25mg) Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma NCT07283731Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Zanzalintinib, Pembrolizumab A Study of KC1036 in Adolescents With Advanced Ewing Sarcoma NCT06564272Phase 21 site📍 Beijing Beijing Konruns Pharmaceutical Co., Ltd. · Tests: KC1036 Lenvatinib for Advanced Bone and Soft Tissue Sarcoma NCT05617859Phase 21 site📍 Zhengzhou Henan Cancer Hospital · Tests: Lenvatinib mesylate capsule Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies NCT07064018Phase 1, Phase 21 site📍 Orange University of California, Irvine · Tests: Spedox-6, Pegfilgrastim, Filgrastim A Study of CRD3874-SI in People With Solid Tumors NCT06021626Phase 17 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: CRD3874 BostonGene and Exigent Genomic INsight Study NCT06272864n/a7 sites📍 Rogers📍 Stockton📍 Fort Wayne BostonGene A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors NCT06508307Phase 11 site📍 Zhengzhou GONGCHU Biotechnology Co., Ltd · Tests: A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patients With Advanced Solid Tumors Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion NCT05245500Phase 125 sites📍 Phoenix📍 Lone Tree📍 Jacksonville Bristol-Myers Squibb · Tests: MRTX1719 Efficacy and Safety of Envafolimab Plus Doxorubicin and Ifosfamide for Advanced Soft Tissue Sarcoma NCT07243626Phase 21 site📍 Hanzhong Second Affiliated Hospital, Zhejiang University, School of … · Tests: Envafolimab combined with an AI regimen (doxorubicin and ifosfamide) Tumor Neoantigen Vaccine SarVac Combined With Tumor Specific Lymphocyte Reinfusion in the Treatment of Advanced Sarcoma NCT07648069Phase 11 site📍 Guangzhou Sun Yat-sen University · Tests: Neoantigen vaccine + specific lymphocytes + anti-PD1 antibody, Neoantigen vaccine + anti-PD1 antibody A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation NCT07458347Phase 19 sites📍 Los Angeles📍 Sarasota📍 Tampa Kestrel Therapeutics, Inc. · Tests: KST-6051, Gemcitabine/nab-paclitaxel, Cetuximab, Pembrolizumab, mFOLFOX6 A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg NCT04332874Phase 27 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Isolated Limb Infusion, Pembrolizumab, infusion of melphalan and dactinomycin
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy